Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Safety of PDT-Photofrin® Prior to Lung Surgery

ClinicalTrials.gov ID: NCT03344861

Public ClinicalTrials.gov record NCT03344861. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.

Study identification

NCT ID
NCT03344861
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Concordia Laboratories Inc.
Industry
Enrollment
10 participants

Conditions and interventions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 14, 2017 (Actual)
Primary completion
Mar 22, 2019 (Actual)
Completion
Mar 22, 2019 (Actual)
Last update posted
Jan 13, 2020

2017 – 2019

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048 —
University of Colorado Denver Colorado 80045 —
Moffitt Cancer Center Tampa Florida 33612 —
Cancer Treatment Centers of America/Southeastern Atlanta Georgia 30265 —
AMITA Health Alexian Brothers Medical Center Elk Grove Village Illinois 60007 —
Dubois Medical Center DuBois Pennsylvania 15801 —
UT MD Anderson Cancer Center Houston Texas 77030 —
Providence Health & Services Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03344861, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03344861 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →